Technologies
Interstitial NS brings together a unique portfolio of technologies combining the improved efficacy of nano-pharmaceutical formulations with innovative delivery systems. These technologies will revolutionise the approach to drug delivery and provide non-invasive, consumer friendly delivery systems.
The Transdermal NanoMAP platform enables the delivery of nanostructured large molecule drugs including pharmaceuticals, therapeutic proteins and hormones and vaccines using micro-array patches (NanoMAPs). NanoMAPs are a non-invasive, painless and blood-free form of drug delivery. The delivery platform utilises the nVac technology for the delivery of adjuvant free vaccines. More…
The Pulmonary nanoparticulate delivery technology targets the delivery of nanostructured pharmaceutical reagents in a liquid form using a non-invasive, user and dose controlled inhaler system. The system utilises the proprietary SAW technology for the controlled production of micro and nanodroplets. The Pulmonary technology is currently under development for the delivery of insulin. More…
Incellution is a unique bio-engineering process for intra-cell modification, using the cells natural improvement process to optimise protein-based therapeutics and reagents. InCellution can be used with many therapeutic and diagnostic drugs to improve their effectiveness generally, and for delivery using the Interstitial NS Transdermal and Pulmonary technologies. More…
Call us on +61 3 9905 8618 or contact us for more information.
|
